Cell activation via CD44 occurs in advanced stages of squamous cell carcinogenesis

Carcinogenesis

Volumn 21, Issue 5, 2000, Pages 893-900

  Bruno, Silvia ^a   Fabbi, Marina ^b   Tiso, Micaela ^a   Santamaria, Barbara ^a   Ghiotto, Fabio ^a   Saverino, Daniele ^a   Tenca, Claudya ^a   Zarcone, Daniela ^a   Ferrini, Silvano ^b   Ciccone, Ermanno ^a   Grossi, Carlo E ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; HERMES ANTIGEN; MESSENGER RNA; MONOCLONAL ANTIBODY; RETINOID;

ANTIGEN EXPRESSION; ARTICLE; CALCIUM MOBILIZATION; CANCER CELL CULTURE; CARCINOGENESIS; CELL STIMULATION; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; KERATINOCYTE; LYMPHOKINE ACTIVATED KILLER CELL; ONCOGENE H RAS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; VIRUS ONCOGENE; WART VIRUS;

EID: 0034020638     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.5.893     Document Type: Article

References (37)

1. Naor, D., Sionov, R.V. and Ish-Shalom, D. (1997) CD44: structure, function and association with the malignant process. Adv. Cancer Res., 71, 241-319.
2. Kincade, P.W., Zheng, Z., Katoh, S. and Hanson, L. (1997) The importance of cellular environment to function of the CD44 matrix receptor. Curr. Opin. Cell Biol., 9, 635-642.
3. Skelton, T.R, Zeng, C., Nocks, A. and Stamenkovic, I. (1998) Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J. Cell Biol., 140, 431-446.
4. Jalkanen, S., Jalkanen, M., Bargatze, R., Tammi, M. and Butcher, E.C. (1988) Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J. Immunol., 141, 1615-1623.
5. Lokeshwar, V.B., Fregien, N. and Bourguignon, L.Y.W. (1994) Ankyrin-binding domain of CD44 (GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J. Cell Biol., 126, 1099-1109.
6. Tzukita, T., Oishi, K., Sato, N., Sagara, J., Kawai, A. and Tzukita, S. (1994) ERM family members as molecular linkers between CD44 and actin-based cytoskeleton. J. Cell Biol., 126, 391-421.
7. Taher, T.E., Smit, L., Griffioen, A.W., Schilder-Tol, E.J., Borst, J. and Pals, S.T. (1996) Signaling through CD44 is mediated through tyrosine kinases. Association with p561ck in T lymphocytes. J. Biol. Chem., 271, 2863-2867.
8. Galandrini, R., Galluzzo, E., Albi, N., Grossi, C.E. and Velardi, A. (1994) Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells. J. Immunol., 153, 21-31.
9. Galluzzo, E., Albi, N., Fiorucci, S., Merigiola, C., Ruggeri, L., Tosti, A., Grossi, C.E. and Velardi, A. (1995) Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells. Eur. J. Immunol., 25, 2932-2939.
10. Ayroldi, E., Cannarile, L., Migliorati, G., Bartoli, A., Nicoletti, I. and Riccard, C. (1995) CD44 (Pgp-1) inhibits CD3 and dexamethasone-induced apoptosis. Blood, 86, 2672-2678.
11. Henke, C., Bitterman, P., Roongta, U., Ingbar, D. and Polunovsky, V. (1996) Induction of fibroblast apoptosis by anti-CD44 antibody: implications for the treatment of fibroproliferative lung disease. Am. J. Pathol., 149, 1639-1650.
12. Bourguignon, L.Y.W., Zhu, D. and Zhu, H. (1998) CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression. Front. Biosci., 3, d637-d649.
13. Moll, J., Khaldoyanidi, S., Sleeman, J.P., Achtnich, M., Preuss, I., Ponta, H. and Herrlich, P. (1998) Two different functions for CD44 proteins in human myelopoiesis. J. Clin. Invest., 102, 1024-1034.
14. Khaldoyanidi, S., Moll, J., Karakhanova, S., Herrlich, P. and Ponta, H. (1999) Hyaluronate-enhanced hematopoiesis: two different receptors trigger the release of interleukin-1beta and interleukin-6 from bone marrow macrophages. Blood, 94, 940-949.
15. Goodison, S. and Tarin, D. (1998) Clinical implications of anomalous CD44 gene expression in neoplasia. Front. Biosci., 3, e89-e109.
16. Hudson, D.L., Speight, P.M. and Watt, F.M. (1996) Altered expression of CD44 isoforms in squamous-cell carcinomas and cell lines derived from them. Int. J. Cancer, 66, 457-463.
17. Soukka, T., Salmi, M., Joensuu, H., Hakkinen, L., Sointu, P., Koulu, L., Kalimo, K., Klemi, P., Grenman, R. and Jalkanen, S. (1997) Regulation of CD44v6-containing isoforms during proliferation of normal and malignant epithelial cells. Cancer Res., 57, 2281-2286.
18. Saegusa, M., Hashimura, M., Machida, D. and Okayasu, I. (1999) Down-regulation of CD44 standard and variant isoforms during the development and progression of uterine cervical tumours. J. Pathol., 187, 173-183.
19. Van Hal, N.L., van Dongen, G.A., Stigter-Van Walsum, M., Snow, G.B. and Brakenhoff, R.H. (1999) Characterization of cd44v6 isoforms in head-and-neck squamous-cell carcinoma. Int. J. Cancer, 82, 837-845.
20. DiPaolo, J.A., Woodworth, C.D., Popescu, N.C., Notario, V. and Doniger, J. (1989) Induction of human cervical squamous carcinoma by sequential transfection with human papillomavirus 16 DNA and viral Harvey ras. Oncogene, 4, 395-399.
21. Hodivala, K.J., Pei, X.-F., Liu, Q.-Y, Jones, P.H., Rytina, E.R.C., Gilbert, C., Singer, A. and Watt, F.M. (1994) Integrin expression and function in HPV16-immortalised human keratinocytes in the presence or absence of v-HA-ras. Comparison with cervical intraepithelial neoplasia, Oncogene, 9, 943-948.
22. Screaton, G.R., Bell, M.V., Jackson, D.G., Cornelis, F.B., Gerth, U. and Bell, J.I. (1992) Genomic structure of the DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl Acad. Sci. USA, 89, 12160-12164.
23. Mathor, M.B., Ferrari, G., Dellambra, E., Cilli, M., Mavilio, F., Cancedda, R. and De Luca, M. (1996) Clonal analysis of stably transduced human epidermal stem cells in culture. Proc. Natl Acad. Sci. USA, 93, 10371-10376.
24. Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorczyca, W., Hotz, M.A., Lassota, P. and Traganos, F. (1992) Features of apoptotic cells measured by flow cytometry. Cytometry, 13, 795-808.
25. Saverino, D., Tenca, C., Zarcone, D., Merlo, A., Megiovanni, A.M., Valle, M.T., Manca, F., Grossi, C.E. and Ciccone, E. (1999) CTLA-4(CD152) inhibits the specific lysis mediated by human cytolytic T lymphocytes in a clonally distributed fashion. J. Immunol., 162, 651-658.
26. Galandrini, R., Albi, N., Tripodi, G., Zarcone, D., Terenzi, A., Moretta, A., Grossi, C.E. and Velardi, A. (1993) Antibodies to CD44 trigger effector functions of human T cell clones. J. Immunol., 150, 4225-1235.
27. Schwartz, A., Marti, G.E., Poon, R., Gratama, J.W. and Fernandez-Repollet, E. (1998) Standardizing flow cytometry: a classification system of fluorescence standards used for flow cytometry. Cytometry, 33, 106-114.
28. ++ indicators with greatly improved flourescence properties. J. Biol. Chem., 260, 3440-3450.
29. Oridate, N., Suzuki, S., Higuchi, M., Mitchell, M.F., Hong, W.K and Lotan, R. (1997) Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells. J. Natl Cancer Inst., 89, 1191-1198.
30. Trochon, V., Mabilat, C., Bertrand, P., Legrand, Y., Smadja-Joffe, F., Soria, C., Delpech, B. and Lu, H. (1996) Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro. Int. J. Cancer, 66, 664-668.
31. Frisch, S.M. and Ruoslahti, E. (1997) Integrins and anoikis. Curr. Opin. Cell Biol., 9, 701-706.
32. 2-. Exp. Cell Res., 212, 409-413.
33. Medina-Martinez, O., Vallejo, V., Guido, M.C. and Garcia-Carranca, A. (1997) Ha-ras oncogene-induced transcription of human papillomavirus type 18 E6 and E7 oncogenes. Mol. Carcinog., 19, 83-90.
34. Jones, D.L., Alani, R.M. and Munger, K. (1997) The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev., 11, 2101-2111.
35. Song, S., Gulliver, G.A. and Lambert, P.F. (1998) Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways. Proc. Natl Acad. Sci. USA, 95, 2290-2295.
36. Martin, L.G., Demers, G.W. and Galloway, D.A. (1998) Disruption of the G1/S transition in human papillomavirus type 16 E7-expressing human cells is associated with altered regulation of cyclin E. J. Virol., 72, 975-985.
37. Martinez, L.A., Chen, Y., Fischer, S.M. and Conti, C.J. (1999) Coordinated changes in cell cycle machinery occur during keratinocyte terminal differentiation. Oncogene, 18, 397-406.